Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference
about
The best of both worlds - managing the cancer, saving the bone.A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites.The role of the bone microenvironment in skeletal metastasis.Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
P2860
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Advances in treating metastati ...... the First Cambridge Conference
@ast
Advances in treating metastati ...... the First Cambridge Conference
@en
type
label
Advances in treating metastati ...... the First Cambridge Conference
@ast
Advances in treating metastati ...... the First Cambridge Conference
@en
prefLabel
Advances in treating metastati ...... the First Cambridge Conference
@ast
Advances in treating metastati ...... the First Cambridge Conference
@en
P2093
P2860
P1476
Advances in treating metastati ...... the First Cambridge Conference
@en
P2093
Allan Lipton
Brendan F Boyce
Charles S Cleeland
Denis R Clohisy
G David Roodman
James R Berenson
Jean-Jacques Body
Katherine N Weilbaecher
Larry J Suva
Laura King
P2860
P304
6209s-6212s
P356
10.1158/1078-0432.CCR-06-1213
P407
P433
P577
2006-10-01T00:00:00Z